Research & Development

Recce Pharmaceuticals Secures $15.8M to Advance Phase 3 Trials
Research & Development Recce Pharmaceuticals Secures $15.8M to Advance Phase 3 Trials

Recce Pharmaceuticals, a Sydney-based biotechnology company, has successfully raised A$15.8 million to advance its groundbreaking anti-infective drugs into Phase 3 trials. This funding was obtained through a combination of private placement and an entitlement offer. Recce's synthetic

How Is Tango Therapeutics Navigating a Challenging Biotech Market?
Research & Development How Is Tango Therapeutics Navigating a Challenging Biotech Market?

Tango Therapeutics, a biotechnology company specializing in cancer treatments, has taken significant measures to address the challenging financial landscape. Recently, the company announced layoffs affecting approximately 20% of its workforce, a strategic move designed to extend its cash runway. As

Genetic Insights into Human Height: Polygenic and Monogenic Factors
Research & Development Genetic Insights into Human Height: Polygenic and Monogenic Factors

Ivan Kairatov, a renowned Biopharma expert, has an impressive background in tech and innovation within the industry, as well as extensive experience in research and development. His insights into genetic factors influencing human height offer a compelling look into the intricate blueprint that

Sulforaphane Supplement Shows Promise in Preventing Lung Cancer
Research & Development Sulforaphane Supplement Shows Promise in Preventing Lung Cancer

In a groundbreaking study, researchers have uncovered promising evidence suggesting that sulforaphane, a compound found in cruciferous vegetables like broccoli, can play a significant role in preventing lung cancer, particularly among former smokers. As the leading cause of cancer-related deaths,

Imipridones and Standard Treatment Show Promise for Glioblastoma
Research & Development Imipridones and Standard Treatment Show Promise for Glioblastoma

Glioblastoma, one of the most aggressive and treatment-resistant forms of brain cancer, presents a dire prognosis even with current standard treatment regimens including surgery, radiation, and the chemotherapy drug temozolomide (TMZ). However, a groundbreaking study published in Volume 16 of

Will Early-Career Research Transform Cancer Treatment by 2025?
Research & Development Will Early-Career Research Transform Cancer Treatment by 2025?

The field of cancer research has witnessed significant strides over the years, yet the journey to finding highly effective treatments remains complex and challenging. A pivotal aspect driving this progress is the contribution of early-career researchers, whose innovative ideas and fresh

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later